1. Home
  2. NXTC vs YJ Comparison

NXTC vs YJ Comparison

Compare NXTC & YJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXTC
  • YJ
  • Stock Information
  • Founded
  • NXTC 2015
  • YJ 2015
  • Country
  • NXTC United States
  • YJ China
  • Employees
  • NXTC N/A
  • YJ N/A
  • Industry
  • NXTC Biotechnology: Pharmaceutical Preparations
  • YJ Other Specialty Stores
  • Sector
  • NXTC Health Care
  • YJ Consumer Discretionary
  • Exchange
  • NXTC Nasdaq
  • YJ Nasdaq
  • Market Cap
  • NXTC 13.9M
  • YJ 7.9M
  • IPO Year
  • NXTC 2019
  • YJ 2019
  • Fundamental
  • Price
  • NXTC $0.49
  • YJ $1.55
  • Analyst Decision
  • NXTC Strong Buy
  • YJ
  • Analyst Count
  • NXTC 2
  • YJ 0
  • Target Price
  • NXTC $3.50
  • YJ N/A
  • AVG Volume (30 Days)
  • NXTC 141.9K
  • YJ 9.2K
  • Earning Date
  • NXTC 05-01-2025
  • YJ 06-10-2025
  • Dividend Yield
  • NXTC N/A
  • YJ N/A
  • EPS Growth
  • NXTC N/A
  • YJ N/A
  • EPS
  • NXTC N/A
  • YJ N/A
  • Revenue
  • NXTC N/A
  • YJ $57,219,520.00
  • Revenue This Year
  • NXTC N/A
  • YJ N/A
  • Revenue Next Year
  • NXTC N/A
  • YJ N/A
  • P/E Ratio
  • NXTC N/A
  • YJ N/A
  • Revenue Growth
  • NXTC N/A
  • YJ N/A
  • 52 Week Low
  • NXTC $0.22
  • YJ $1.37
  • 52 Week High
  • NXTC $1.82
  • YJ $3.16
  • Technical
  • Relative Strength Index (RSI)
  • NXTC 55.20
  • YJ 45.37
  • Support Level
  • NXTC $0.45
  • YJ $1.45
  • Resistance Level
  • NXTC $0.52
  • YJ $1.63
  • Average True Range (ATR)
  • NXTC 0.05
  • YJ 0.06
  • MACD
  • NXTC 0.01
  • YJ 0.00
  • Stochastic Oscillator
  • NXTC 66.47
  • YJ 33.33

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in the PRC.

Share on Social Networks: